The June MISTIE III webinar focused on one of the most important tasks in preparing for the launch of the trial this fall -- designing the electronic data capture (EDC) system forms.  Steve Mayo gave a presentation reviewing the form designs from the prior MISTIE and CLEAR trials and the considerations that are currently going into designing the online case report forms for MISTIE III.

Coordinators are invited to get involved in these early planning efforts and provide suggests for how to optimize and simplify data collection for this new trial.

BATTLE OF NEW ORLEANS 2013

A Dedication to Dan Hanley and the CLEAR and MISTIE Project Teams

Composed and sung in Waikiki on 05-February-2013 by Keith Gregson while attending the International Stroke Conference. It is set to an old cajun fiddle tune and dedicated to Dan Hanley and members of the CLEAR and MISTIE teams at JHU, Baltimore, Maryland. Keith is the spouse of Barbara Gregson, who manages the STICH-II trial and is a member of the CLEAR steering committee.

In 2013 we took a little trip to a famous city on the mighty Mississip
To watch Ray Lewis and his Superbowl machine meet the 49ers in the ‘town’ of New Orleans

Dr. Daniel Hanley, co-principal investigator for the MISTIE clinical trial, was a featured speaker this week at the 2013 International Stroke conference (ISC) in Honolulu as he presented 365-day results from this phase-II clinical trial. MISTIE is an acronym for Minimally Invasive Surgery + rt-PA for Intracerebral Hemorrhage (ICH) Evacuation. ICH is a type of stroke caused by bleeding within the brain, often the result of uncontrolled hypertension. It is also referred to as cerebral stroke or hemorrhagic stroke.

This recently-completed proof-of-concept trial evaluated the use of tPA (a thrombolytic or clot-busting drug) delivered via a catheter placed under CT (a series of x-ray images) guidance. Data from the 123 patients enrolled across 26 medical centers provides ground-breaking evidence, which now needs to be verified in a larger phase-III trial, that this technique offers future promise for reducing the high rate of death and serious disability in ICH patients. Preliminary results were presented at last year's conference. Now that study participants have reached the one-year mark, the final results are even more encouraging. A summary of these results have been published on the American Stroke Society's ISC website -- scroll to the bottom to see Dr. Hanley's late-breaking presentation materials.

Aloha Friends! In just a few short days, we will be in sunny Honolulu at the International Stroke Conference. During the conference this year, we have many exciting programs and presentations about the findings from MISTIE II and future plans for MISTIE III. Continue reading for details on all events. We hope to see you there!

Aloha Friends! In just a few short days, we will be in sunny Honolulu at the International Stroke Conference. In addition to our CLEAR III Annual Meeting on Tuesday night, we have many other exciting programs and presentations during the conference. Continue reading for details on all events. We hope to see you there!